(19)
(11) EP 2 344 487 A1

(12)

(43) Date of publication:
20.07.2011 Bulletin 2011/29

(21) Application number: 09815517.9

(22) Date of filing: 14.09.2009
(51) International Patent Classification (IPC): 
C07D 417/14(2006.01)
A61K 31/506(2006.01)
A61K 31/4709(2006.01)
A61P 31/14(2006.01)
(86) International application number:
PCT/CA2009/001237
(87) International publication number:
WO 2010/034105 (01.04.2010 Gazette 2010/13)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
Designated Extension States:
AL BA RS

(30) Priority: 23.09.2008 US 99292 P
12.06.2009 US 186632 P

(71) Applicant: Boehringer Ingelheim International GmbH
55216 Ingelheim (DE)

(72) Inventors:
  • O'MEARA, Jeffrey
    Laval Québec H7S 2G5 (CA)
  • BORDELEAU, Josée
    Laval Québec H7S 2G5 (CA)
  • GORYS, Vida
    Laval Québec H7S 2G5 (CA)
  • LEBLANC, Mélissa
    Laval Québec H7S 2G5 (CA)
  • LENHARDT, Kirsten
    55216 Ingelheim am Rhein (DE)
  • LLINAS-BRUNET, Montse
    Laval Québec H7S 2G5 (CA)
  • PARISIEN, Mathieu
    Laval Québec H7S 2G5 (CA)
  • POUPART, Marc-André
    Laval Québec H7S 2G5 (CA)

(74) Representative: Hammann, Heinz 
Boehringer Ingelheim GmbH Corporate Patents Binger Strasse 173
55216 Ingelheim am Rhein
55216 Ingelheim am Rhein (DE)

   


(54) HEPATITIS C INHIBITOR COMPOUNDS